menu
    • menu

    Company profile for Sensei Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sensei BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    620 Professional Drive Gaithersburg, MD 20879
    Telephone
    Telephone
    +1.240.243.8000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.senseibio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sensei Shrinks Workforce By 65% As Layoff Warning Comes To Pass
    Sensei Shrinks Workforce By 65% As Layoff Warning Comes To Pass

    14 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sensei-shrinks-workforce-65-warnings-layoffs-come-pass

    FIERCE BIOTECH
    14 Nov 2025
    Share Share
    Sensei Bio Initiates Strategic Review To Boost Shareholder Value
    Sensei Bio Initiates Strategic Review To Boost Shareholder Value

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177470/0/en/Sensei-Biotherapeutics-Announces-Initiation-of-Strategic-Review-to-Maximize-Shareholder-Value.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Sensei Shows Durable PFS for Solnerstotug in PD-L1 Tumors
    Sensei Shows Durable PFS for Solnerstotug in PD-L1 Tumors

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168569/0/en/Sensei-Biotherapeutics-Reports-New-Clinical-Results-Highlighting-Durable-Progression-Free-Survival-Data-for-Solnerstotug-in-PD-L-1-Resistant-Tumors-at-the-ESMO-Congress-2025.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    Sensei Bio To Host Virtual Kol Event On Solnerstotug In Pd-(l)1
    Sensei Bio To Host Virtual Kol Event On Solnerstotug In Pd-(l)1

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154567/0/en/Sensei-Biotherapeutics-to-Host-Virtual-KOL-Event-to-Discuss-Full-Dose-Expansion-Data-for-Solnerstotug-in-PD-L-1-Resistant-Tumors-on-October-20-2025.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Sensei Biotherapeutics to Present at H.C. Wainwright Conference
    Sensei Biotherapeutics to Present at H.C. Wainwright Conference

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143511/0/en/Sensei-Biotherapeutics-to-Participate-in-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share
    Sensei Biotherapeutics Reports Q2 2025 Financials, Updates
    Sensei Biotherapeutics Reports Q2 2025 Financials, Updates

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127236/0/en/Sensei-Biotherapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search